Biblio

Export 3284 results:
Author Title Type [ Year(Desc)]
2018
P. Chan, Saleem, M., Herrmann, N., Mielke, M. M., Haughey, N. J., Oh, P. I., Kiss, A., and Lanctôt, K. L., “Ceramide Accumulation Is Associated with Declining Verbal Memory in Coronary Artery Disease Patients: An Observational Study.”, J Alzheimers Dis, vol. 64, no. 4, pp. 1235-1246, 2018.
D. Renard, Tatu, L., Collombier, L., Wacongne, A., Ayrignac, X., Charif, M., Boukriche, Y., Chiper, L., Fourcade, G., Azakri, S., Gaillard, N., Mercier, E., Lehmann, S., and Thouvenot, E., “Cerebral Amyloid Angiopathy and Cerebral Amyloid Angiopathy-Related Inflammation: Comparison of Hemorrhagic and DWI MRI Features.”, J Alzheimers Dis, vol. 64, no. 4, pp. 1113-1121, 2018.
D. M. Kamara, Gangishetti, U., Gearing, M., Willis-Parker, M., Zhao, L., Hu, W. T., and Walker, L. C., “Cerebral Amyloid Angiopathy: Similarity in African-Americans and Caucasians with Alzheimer's Disease.”, J Alzheimers Dis, vol. 62, no. 4, pp. 1815-1826, 2018.
J. J. Claus, Coenen, M., Staekenborg, S. S., Schuur, J., Tielkes, C. E. M., Koster, P., and Scheltens, P., “Cerebral White Matter Lesions have Low Impact on Cognitive Function in a Large Elderly Memory Clinic Population.”, J Alzheimers Dis, 2018.
D. - W. Chen, Wang, J., Zhang, L. - L., Wang, Y. - J., and Gao, C. - Y., “Cerebrospinal Fluid Amyloid-β Levels are Increased in Patients with Insomnia.”, J Alzheimers Dis, vol. 61, no. 2, pp. 645-651, 2018.
B. M. Bettcher, Johnson, S. C., Fitch, R., Casaletto, K. B., Heffernan, K. S., Asthana, S., Zetterberg, H., Blennow, K., Carlsson, C. M., Neuhaus, J., Bendlin, B. B., and Kramer, J. H., “Cerebrospinal Fluid and Plasma Levels of Inflammation Differentially Relate to CNS Markers of Alzheimer's Disease Pathology and Neuronal Damage.”, J Alzheimers Dis, vol. 62, no. 1, pp. 385-397, 2018.
C. B. Malpas, Saling, M. M., Velakoulis, D., Desmond, P., Hicks, R. J., Zetterberg, H., Blennow, K., and O'Brien, T. J., “Cerebrospinal Fluid Biomarkers are Differentially Related to Structural and Functional Changes in Dementia of the Alzheimer's Type.”, J Alzheimers Dis, vol. 62, no. 1, pp. 417-427, 2018.
M. Bjerke and Engelborghs, S., “Cerebrospinal Fluid Biomarkers for Early and Differential Alzheimer's Disease Diagnosis.”, J Alzheimers Dis, vol. 62, no. 3, pp. 1199-1209, 2018.
L. Parnetti and Eusebi, P., “Cerebrospinal Fluid Biomarkers in Alzheimer's Disease: An Invaluable Tool for Clinical Diagnosis and Trial Enrichment.”, J Alzheimers Dis, vol. 64, no. s1, pp. S281-S287, 2018.
S. Abu-Rumeileh, Mometto, N., Bartoletti-Stella, A., Polischi, B., Oppi, F., Poda, R., Stanzani-Maserati, M., Cortelli, P., Liguori, R., Capellari, S., and Parchi, P., “Cerebrospinal Fluid Biomarkers in Patients with Frontotemporal Dementia Spectrum: A Single-Center Study.”, J Alzheimers Dis, vol. 66, no. 2, pp. 551-563, 2018.
A. Kimura, Yoshikura, N., Hayashi, Y., and Inuzuka, T., “Cerebrospinal Fluid C-C Motif Chemokine Ligand 2 Correlates with Brain Atrophy and Cognitive Impairment in Alzheimer's Disease.”, J Alzheimers Dis, vol. 61, no. 2, pp. 581-588, 2018.
N. P. Rocha, Toledo, A., Corgosinho, L. T. S., de Souza, L. C., Guimarães, H. C., Resende, E. P. F., Braz, N. F. T., Gomes, K. B., Silva, A. C. Simoes E., Caramelli, P., and Teixeira, A. L., “Cerebrospinal Fluid Levels of Angiotensin-Converting Enzyme Are Associated with Amyloid-β42 Burden in Alzheimer's Disease.”, J Alzheimers Dis, vol. 64, no. 4, pp. 1085-1090, 2018.
D. Renard, Collombier, L., Demattei, C., Wacongne, A., Charif, M., Ayrignac, X., Azakri, S., Gaillard, N., Boudousq, V., Lehmann, S., de Champfleur, N. Menjot, and Thouvenot, E., “Cerebrospinal Fluid, MRI, and Florbetaben-PET in Cerebral Amyloid Angiopathy-Related Inflammation.”, J Alzheimers Dis, vol. 61, no. 3, pp. 1107-1117, 2018.
C. Liguori, Mercuri, N. Biagio, Nuccetelli, M., Izzi, F., Bernardini, S., and Placidi, F., “Cerebrospinal Fluid Orexin Levels and Nocturnal Sleep Disruption in Alzheimer's Disease Patients Showing Neuropsychiatric Symptoms.”, J Alzheimers Dis, vol. 66, no. 3, pp. 993-999, 2018.
A. Piriz, Reyes, D., Narkhede, A., Guzman, V. A., Viqar, F., Meier, I. B., Budge, M., Mena, P., Dashnaw, S., Lee, J., Reitz, C., Gutierrez, J., Campos, L., Medrano, M., Lantigua, R., Mayeux, R., and Brickman, A. M., “Cerebrovascular Disease and Neurodegeneration in Alzheimer's Disease with and without a Strong Family History: A Pilot Magnetic Resonance Imaging Study in Dominican Republic.”, J Alzheimers Dis, vol. 66, no. 4, pp. 1519-1528, 2018.
E. - Y. Lim, Yang, D. - W., Cho, A. - H., and Shim, Y. S., “Cerebrovascular Hemodynamics on Transcranial Doppler Ultrasonography and Cognitive Decline in Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 65, no. 2, pp. 651-657, 2018.
R. Kustra, Awh, C. C., Rojas-Fernandez, C., and Zanke, B., “CFH and ARMS2 Polymorphisms Interact with Zinc Supplements in Cognitive Impairment in the Women's Health Initiative Hormone Trial.”, J Alzheimers Dis, vol. 66, no. 2, pp. 707-715, 2018.
N. A. Sobol, Dall, C. Have, Høgh, P., Hoffmann, K., Frederiksen, K. Steen, Vogel, A., Siersma, V., Waldemar, G., Hasselbalch, S. G., and Beyer, N., “Change in Fitness and the Relation to Change in Cognition and Neuropsychiatric Symptoms After Aerobic Exercise in Patients with Mild Alzheimer's Disease.”, J Alzheimers Dis, vol. 65, no. 1, pp. 137-145, 2018.
C. Akiba, Nakajima, M., Miyajima, M., Ogino, I., Motoi, Y., Kawamura, K., Adachi, S., Kondo, A., Sugano, H., Tokuda, T., Irie, K., and Arai, H., “Change of Amyloid-β 1-42 Toxic Conformer Ratio After Cerebrospinal Fluid Diversion Predicts Long-Term Cognitive Outcome in Patients with Idiopathic Normal Pressure Hydrocephalus.”, J Alzheimers Dis, vol. 63, no. 3, pp. 989-1002, 2018.
G. Silva Leandro, Evangelista, A. Feijó, Lobo, R. Rebouças, Xavier, D. Jordão, Moriguti, J. César, and Sakamoto-Hojo, E. Tiemi, “Changes in Expression Profiles Revealed by Transcriptomic Analysis in Peripheral Blood Mononuclear Cells of Alzheimer's Disease Patients.”, J Alzheimers Dis, vol. 66, no. 4, pp. 1483-1495, 2018.
J. R. Hall, Wiechmann, A., Johnson, L. A., Edwards, M., and O'Bryant, S. E., “Characteristics of Cognitively Normal Mexican-Americans with Cognitive Complaints.”, J Alzheimers Dis, vol. 61, no. 4, pp. 1485-1492, 2018.
A. Baird, Brancatisano, O., Gelding, R., and Thompson, W. Forde, “Characterization of Music and Photograph Evoked Autobiographical Memories in People with Alzheimer's Disease.”, J Alzheimers Dis, vol. 66, no. 2, pp. 693-706, 2018.
A. Reuben, “Childhood Lead Exposure and Adult Neurodegenerative Disease.”, J Alzheimers Dis, vol. 64, no. 1, pp. 17-42, 2018.
Q. - Q. Xu, Shan, C. - S., Wang, Y., Shi, Y. - H., Zhang, Q. - H., and Zheng, G. - Q., “Chinese Herbal Medicine for Vascular Dementia: A Systematic Review and Meta-Analysis of High-Quality Randomized Controlled Trials.”, J Alzheimers Dis, vol. 62, no. 1, pp. 429-456, 2018.
Y. Huang, Guo, B., Shi, B., Gao, Q., and Zhou, Q., “Chinese Herbal Medicine Xueshuantong Enhances Cerebral Blood Flow and Improves Neural Functions in Alzheimer's Disease Mice.”, J Alzheimers Dis, vol. 63, no. 3, pp. 1089-1107, 2018.

Pages